Temasek Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,125,816
Closed -$696M 53
2018
Q4
$696M Hold
11,125,816
4.79% 4
2018
Q3
$859M Hold
11,125,816
5% 3
2018
Q2
$788M Hold
11,125,816
4.14% 3
2018
Q1
$839M Hold
11,125,816
4.6% 3
2017
Q4
$797M Hold
11,125,816
4.9% 3
2017
Q3
$901M Hold
11,125,816
5.25% 3
2017
Q2
$787M Sell
11,125,816
-3,318,400
-23% -$221M 5.08% 4
2017
Q1
$981M Buy
14,444,216
+613,700
+4% +$43.2M 7.32% 3
2016
Q4
$990M Hold
13,830,516
7.93% 3
2016
Q3
$1.09B Hold
13,830,516
8.86% 3
2016
Q2
$1.15B Hold
13,830,516
9.01% 3
2016
Q1
$1.27B Buy
13,830,516
+1,035,592
+8% +$93.4M 10.01% 3
2015
Q4
$1.29B Buy
12,794,924
+1,372,977
+12% +$143M 9.83% 3
2015
Q3
$1.12B Sell
11,421,947
-9,350,000
-45% -$1.04B 10.64% 3
2015
Q2
$2.43B Hold
20,771,947
15.2% 3
2015
Q1
$2.04B Buy
20,771,947
+207,418
+1% +$21.1M 15.27% 3
2014
Q4
$1.94B Buy
20,564,529
+7,840,730
+62% +$811M 20.15% 2
2014
Q3
$1.35B Hold
12,723,799
14.4% 3
2014
Q2
$1.05B Buy
12,723,799
+150,000
+1% +$11.7M 15.8% 2
2014
Q1
$891M Buy
12,573,799
+6,927,403
+123% +$543M 13.81% 3
2013
Q4
$424M Buy
+5,646,396
New +$393M 8.78% 4

Other funds holding GILD

Temasek Holdings's GILD Position: Q1 2019 in Review

Temasek Holdings sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 11,125,816 shares — an estimated $696M sold.

Temasek Holdings first reported a position in GILD in Q4 2013 and held it in 21 quarters. The position peaked at $2.43B in Q2 2015. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Temasek Holdings reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Temasek Holdings sold 11,125,816 Gilead Sciences shares in Q1 2019, an estimated $696M.
  • Temasek Holdings first reported a position in Gilead Sciences in Q4 2013 and held it in 21 quarters.
  • Temasek Holdings's Gilead Sciences position peaked at $2.43B in Q2 2015.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Temasek Holdings's 13F filing for Q1 2019, filed 15 May 2019.